Search

everythinglearnresearchcommunity

for

Search:↓

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Women with irregular periods have a higher risk of heart disease.

Some women with PCOS have rare genetic variants linked to the condition.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.